This is the authors' abstract. We don't add key points for this paper.
Objective: To compare clinical outcome of two doses of radioactive iodine 131 therapy given to hyperthyroid patients. Method: We reviewed records of hyperthyroid patients who consulted at an endocrine referral clinic from 1995 to 2005. Diagnosis of hyperthyroidism was based on compatible clinical manifestations and/or suppressed TSH (n=373, N.V. 0.3-4.0uII/ml) and/or elevated FT4 (n=91, N.V. 10.0-25.7 pmol/l). We compared two dose groups of radioactive I 131 therapy, group 1 ( 10 mCi) in terms of requirement for second and/or third radioactive I 131 therapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jesus et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: